Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083997617> ?p ?o ?g. }
- W2083997617 endingPage "80" @default.
- W2083997617 startingPage "72" @default.
- W2083997617 abstract "Atopic dermatitis (AD) and allergic contact dermatitis (ACD) are common allergic and inflammatory skin diseases caused by a combination of eczema, scratching, pruritus, and cutaneous sensitization with allergens. This paper examines whether oleanolic acid acetate (OAA) modulates AD and ACD symptoms by using an existing AD model based on the repeated local exposure of mite extract (Dermatophagoides farinae extract, DFE) and 2,4-dinitrochlorobenzene to the ears of BALB/c mice. In addition, the paper uses a 2,4-dinitrofluorobenzene-sensitized local lymph node assay (LLNA) for the ACD model. The oral administration of OAA over a four-week period attenuated AD symptoms in terms of decreased skin lesions, epidermal thickness, the infiltration of immune cells (CD4⁺ cells, eosinophils, and mast cells), and serum IgE, IgG2a, and histamine levels. The gene expression of Th1, Th2, Th17, and Th22 cytokines was reduced by OAA in the lymph node and ear tissue, and the LLNA verified that OAA suppressed ACD. The oral administration of OAA over a three-day period attenuated ACD symptoms in terms of ear thickness, lymphocyte proliferation, and serum IgG2a levels. The gene expression of Th1, Th2, and Th17 cytokines was reduced by OAA in the thymus and ear tissue. Finally, to define the underlying mechanism, this paper uses a TNF-α/IFN-γ-activated human keratinocyte (HaCaT) model. OAA inhibited the expression of cytokines and chemokines through the downregulation of NF-κB and MAPKs in HaCaT cells. Taken together, the results indicate that OAA inhibited AD and ACD symptoms, suggesting that OAA may be effective in treating allergic skin disorders." @default.
- W2083997617 created "2016-06-24" @default.
- W2083997617 creator A5005487766 @default.
- W2083997617 creator A5011931629 @default.
- W2083997617 creator A5032591267 @default.
- W2083997617 creator A5034003059 @default.
- W2083997617 creator A5037496831 @default.
- W2083997617 creator A5050136351 @default.
- W2083997617 creator A5054814308 @default.
- W2083997617 creator A5057913824 @default.
- W2083997617 creator A5062491635 @default.
- W2083997617 date "2013-05-01" @default.
- W2083997617 modified "2023-10-16" @default.
- W2083997617 title "Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model" @default.
- W2083997617 cites W1542185599 @default.
- W2083997617 cites W1812613913 @default.
- W2083997617 cites W1824222084 @default.
- W2083997617 cites W1973603284 @default.
- W2083997617 cites W1984621842 @default.
- W2083997617 cites W1994033987 @default.
- W2083997617 cites W1995877493 @default.
- W2083997617 cites W2006849630 @default.
- W2083997617 cites W2007412915 @default.
- W2083997617 cites W2010559643 @default.
- W2083997617 cites W2019630945 @default.
- W2083997617 cites W2020548971 @default.
- W2083997617 cites W2024392158 @default.
- W2083997617 cites W2027265343 @default.
- W2083997617 cites W2028862430 @default.
- W2083997617 cites W2030147910 @default.
- W2083997617 cites W2034733837 @default.
- W2083997617 cites W2035914350 @default.
- W2083997617 cites W2041376003 @default.
- W2083997617 cites W2043621848 @default.
- W2083997617 cites W2047154603 @default.
- W2083997617 cites W2050066579 @default.
- W2083997617 cites W2053490614 @default.
- W2083997617 cites W2059174274 @default.
- W2083997617 cites W2060307820 @default.
- W2083997617 cites W2060944699 @default.
- W2083997617 cites W2064968649 @default.
- W2083997617 cites W2066989460 @default.
- W2083997617 cites W2080448616 @default.
- W2083997617 cites W2082086413 @default.
- W2083997617 cites W2082450021 @default.
- W2083997617 cites W2100850228 @default.
- W2083997617 cites W2128110628 @default.
- W2083997617 cites W2131462541 @default.
- W2083997617 cites W2134717682 @default.
- W2083997617 cites W2140299259 @default.
- W2083997617 cites W2141504524 @default.
- W2083997617 cites W2157029495 @default.
- W2083997617 cites W2162201817 @default.
- W2083997617 cites W2164098277 @default.
- W2083997617 cites W4232510995 @default.
- W2083997617 cites W4232685799 @default.
- W2083997617 cites W4239187852 @default.
- W2083997617 doi "https://doi.org/10.1016/j.taap.2013.03.001" @default.
- W2083997617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23499868" @default.
- W2083997617 hasPublicationYear "2013" @default.
- W2083997617 type Work @default.
- W2083997617 sameAs 2083997617 @default.
- W2083997617 citedByCount "63" @default.
- W2083997617 countsByYear W20839976172013 @default.
- W2083997617 countsByYear W20839976172014 @default.
- W2083997617 countsByYear W20839976172015 @default.
- W2083997617 countsByYear W20839976172016 @default.
- W2083997617 countsByYear W20839976172017 @default.
- W2083997617 countsByYear W20839976172018 @default.
- W2083997617 countsByYear W20839976172019 @default.
- W2083997617 countsByYear W20839976172020 @default.
- W2083997617 countsByYear W20839976172021 @default.
- W2083997617 countsByYear W20839976172022 @default.
- W2083997617 countsByYear W20839976172023 @default.
- W2083997617 crossrefType "journal-article" @default.
- W2083997617 hasAuthorship W2083997617A5005487766 @default.
- W2083997617 hasAuthorship W2083997617A5011931629 @default.
- W2083997617 hasAuthorship W2083997617A5032591267 @default.
- W2083997617 hasAuthorship W2083997617A5034003059 @default.
- W2083997617 hasAuthorship W2083997617A5037496831 @default.
- W2083997617 hasAuthorship W2083997617A5050136351 @default.
- W2083997617 hasAuthorship W2083997617A5054814308 @default.
- W2083997617 hasAuthorship W2083997617A5057913824 @default.
- W2083997617 hasAuthorship W2083997617A5062491635 @default.
- W2083997617 hasConcept C118995209 @default.
- W2083997617 hasConcept C13373296 @default.
- W2083997617 hasConcept C164027704 @default.
- W2083997617 hasConcept C203014093 @default.
- W2083997617 hasConcept C207480886 @default.
- W2083997617 hasConcept C2776056826 @default.
- W2083997617 hasConcept C2776217527 @default.
- W2083997617 hasConcept C2776914184 @default.
- W2083997617 hasConcept C2778329239 @default.
- W2083997617 hasConcept C2778786243 @default.
- W2083997617 hasConcept C2780614586 @default.
- W2083997617 hasConcept C3018346242 @default.
- W2083997617 hasConcept C54355233 @default.
- W2083997617 hasConcept C71924100 @default.